Pharmaceuticals
Pharmaceuticals encompass the research, development and manufacturing of drugs for disease treatment and prevention by applying chemistry, pharmacology and medical science. Effective medications and therapies are critical to enhancing patient health outcomes. These medications continue to improve based on growing knowledge of biochemical processes and drug interactions.
Top Stories
-
Feature
21 Oct 2024
Understanding PMBs' role and impact on drug pricing
PBMs shape drug pricing and healthcare costs, but growing market consolidation sparks concerns about less competition, higher prices and fewer options for patients. Continue Reading
By- Alivia Kaylor, MSc, Senior Editor
-
News
18 Oct 2024
Hurricane Helene triggers dialysis and IV fluid shortage
Following Hurricane Helene, damages to a manufacturing plant in North Carolina and subsequent nationwide IV fluid shortages have forced manufacturers to mobilize global networks. Continue Reading
By- Veronica Salib, Associate Editor
-
News
15 Jan 2021
COVID-19, Vaccine Development Trends at JPM21
COVID-19 and other vaccine development efforts dominated conversation at this year’s J.P. Morgan Healthcare Conference. Continue Reading
By- Samantha McGrail
-
News
02 Nov 2020
Epic’s Broad Pharmacy Development Increases But Gaps Remain
Gaps in Epic’s broad pharmacy development include inadequate in-scope medication reporting, incomplete data, and lackluster support after implementation, KLAS found. Continue Reading
By- Samantha McGrail
-
News
29 Oct 2020
Definitive Healthcare Makes Another Key Life Sciences Acquisition
Definitive Healthcare has acquired Monocl with an eye on meeting the medical affairs needs of life sciences companies. Continue Reading
By- Kyle Murphy, PhD, Vice President of Editorial
-
News
16 Oct 2020
10 of the Largest Pharmaceutical Companies by Revenue
The top ten pharmaceutical companies with the highest revenue from Q1 and Q2 of 2020 include Johnson & Johnson, Roche, Sinopharm, Bayer, and Pfizer. Continue Reading
By- Samantha McGrail
-
News
27 May 2020
COVID-19 May Negatively Impact the Biopharmaceutical Industry
The COVID-19 pandemic will cause some biopharmaceutical companies to emerge weaker, dealing with delays in new product launches and with fewer resources to invest in R&D. Continue Reading
By- Samantha McGrail
-
News
14 May 2020
Cybersecurity Best Practices for the Pharma Sector Amid COVID-19
The COVID-19 pandemic has seen a spate of cyberattacks on the health and pharma sectors. Employing cybersecurity best practices will prove crucial to protecting these valuable systems. Continue Reading
By- Jessica Davis
-
News
12 May 2020
Apple Awards $10M to Give Hospitals COVID-19 Testing Kits
The fund will allow COPAN Diagnostics to rapidly accelerate its COVID-19 testing kit supply for hospitals across the US, which have been vital during the pandemic. Continue Reading
By- Samantha McGrail
-
News
22 Apr 2020
BARDA Director Rick Bright Leaves Agency Amid COVID-19 Pandemic
HHS replaces Rick Bright, director of BARDA since 2016, moving him to a new public-private partnership under NIH that will oversee COVID-19 testing platforms. Continue Reading
By- Samantha McGrail
-
News
17 Apr 2020
CRISPR Technology Detects COVID-19 From Respiratory RNA Extracts
New CRISPR- technology detects COVID-19 from respiratory RNA extracts, enabling point-of-care testing outside of the clinical diagnostic laboratory. Continue Reading
By- Samantha McGrail
-
News
30 Mar 2020
FDA Approves Prescription Digital Therapeutic for Chronic Insomnia
Pear Therapeutics receives FDA support for its prescription digital therapeutic that delivers digital cognitive behavioral therapy to chronic insomnia patients. Continue Reading
By- Samantha McGrail
-
News
19 Mar 2020
FDA Approves Roche’s Biomarker Test for At-Risk HPV Infections
The FDA recently approved Roche’s biomarker test, CINtec PLUS Cytology, to simplify decision making and ensure at-risk women receive vital health information. Continue Reading
By- Samantha McGrail
-
News
22 Jan 2020
Eli Lilly Snags $470M for NC Drug Manufacturing Plant
With a $470 million grant, Eli Lilly will open its first manufacturing facility in North Carolina. Continue Reading
By- Ana Mulero
-
News
14 Jan 2020
Definitive Healthcare Acquires PatientFinder, Eyes Life Sciences
The addition of PatientFinder analytics will speed the identification of patient cohorts to improve product development in the life sciences. Continue Reading
By- Kyle Murphy, PhD, Vice President of Editorial
-
News
04 Dec 2019
250K Docs Using Drug Price Transparency Tools, Benefits Checkers
Drug price transparency tools help address high patient costs, medication adherence, and care access. Continue Reading
By- Sara Heath, Executive Editor
-
News
22 Nov 2019
Data Analytics Key in 2020 Pharmaceutical Industry Predictions
The future of healthcare is increasingly digital, and the pharmaceutical industry is no exception. Continue Reading
By- Sara Heath, Executive Editor